Leadless Pacemaker Market: How Is Abbott AVEIR DR Disrupting the Dual-Chamber Market?
Abbott AVEIR DR — the first FDA-approved true dual-chamber leadless pacing system using two communicating devices (one in right atrium, one in right ventricle) providing independent atrial and ventricular sensing and pacing — represents the most commercially significant leadless pacemaker innovation since Micra's original approval, with the Leadless Pacemaker Market reflecting AVEIR...
0 Σχόλια 0 Μοιράστηκε 3 Views 0 Προεπισκόπηση